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Abstract 
Background: Genetic polymorphisms in the complex gene cluster encoding human Fc‑gamma receptors (FcγRs) 
may influence malaria susceptibility and pathogenesis. Studying genetic susceptibility to malaria is ideal among sym‑
patric populations because the distribution of polymorphic genes among such populations can help in the identifica‑
tion malaria candidate genes. This study determined the distribution of three FcyRs single nucleotide polymorphisms 
(SNPs) (FcγRIIB‑rs1050519, FcγRIIC‑rs3933769 and FcγRIIIA‑rs396991) among sympatric Fulani and Dogon children with 
uncomplicated malaria. The association of these SNPs with clinical, malariometric and immunological indices was also 
tested.
Methods: This study involved 242 Fulani and Dogon volunteers from Mali age under 15 years. All SNPs were geno‑
typed with predesigned TaqMan® SNP Genotyping Assays. Genotypic and allelic distribution of SNPs was com‑
pared across ethnic groups using the Fisher exact test. Variations in clinical, malariometric and immunologic indices 
between groups were tested with Kruskal–Wallis H, Mann–Whitney U test and Fisher exact test where appropriate.
Results: The study confirmed known malariometric and immunologic differences between sympatric Fulani and 
non‑Fulani tribes. Parasite density was lower in the Fulani than the Dogon (p < 0.0001). The mutant allele of FcγRIIC 
(rs3933769) was found more frequently in the Fulani than the Dogon (p < 0.0001) while that of FcγRIIIA (rs396991) 
occurred less frequently in the Fulani than Dogon (p = 0.0043). The difference in the mutant allele frequency of 
FcγRIIB (rs1050519) between the two ethnic groups was however not statistically significant (p = 0.064). The mutant 
allele of rs396991 was associated with high malaria‑specific IgG1 and IgG3 in the entire study population and Dogon 
tribe, p = 0.023 and 0.015, respectively. Parasite burden was lower in carriers of the FcγRIIC (rs3933769) mutant allele 
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Background
Variations in malaria susceptibility among populations 
living in endemic areas have been known for decades [1–
3]. Sympatric populations, such as the Fulani and their 
sympatric neighbours, amply demonstrate this phenom-
enon. Epidemiologically, the Fulani have been consist-
ently shown to be naturally less susceptible to malarial 
infections than their sympatric neighbours [2–8]. A 
clear biological explanation of the basis of this protec-
tion is still lacking. The observation of larger spleen sizes 
in the Fulani compared to their sympatric neighbours 
in the 1970s and 1980s suggested that the spleen may 
have a role in protecting the Fulani from malaria [5, 9]. 
Subsequent studies have provided clues to other possi-
ble biological mediators of this interethnic difference in 
malaria susceptibility. For instance, in Burkina Faso, the 
Fulani were shown to have lower parasite densities and 
stronger humoral immune responses to malaria antigens 
than their Mossi and Rimaibes sympatric neighbours [4, 
6]. Similarly, a functional deficiency in T cell regulation 
is thought to contribute to the Fulani’s protection against 
malaria [10]. Several immuno-epidemiology studies have 
reported on the possible roles of different immune fac-
tors in this phenomenon and this has been extensively 
reviewed [11]. A review of the existing body of evidence 
suggests a significant role for immune-mediated mecha-
nisms of protection; however, the immunogenetics of this 
protection are currently poorly explained.
Traditional host genetic factors known to influence 
malaria susceptibility have so far failed to adequately 
explain why the Fulani are less susceptible to malaria 
than their sympatric neighbours [12–15]. Recent malaria 
immunogenetic studies have suggested roles for a few 
genes but that notwithstanding, the immunogenes that 
mediate this protection are yet to be clearly identified 
[16, 17]. Research is ongoing to identify the immuno-
genes that may influence interethnic variability in malaria 
susceptibility. Of all the candidate genes, the Fc gamma 
receptors (FcγRs) for IgG are probably the most exten-
sively studied. FcγRs for IgG are expressed on a variety of 
immune cells, including monocytes and other leucocytes. 
They typically bind to opsonized pathogens to activate 
a variety of cellular immune responses that may culmi-
nate in the control of an infection [18]. Thus, FcγRs are 
thought to be an important link between humoral and 
cellular immune response [18].
Studies on FcγRs polymorphisms and malaria suscep-
tibility have so far focused on the FcγRIIa genotypes, 
which affect binding of different IgG sub-classes. The 
best known of the FcγRs polymorphisms is the FcγRIIa 
(H/R131), which has been associated with levels of anti-
malarial IgG2 and IgG3 antibodies [19, 20]. Compared 
to their sympatric neighbours, the Fulani in Sudan were 
shown to have a higher frequency of the FcγRIIa-H131, 
which is associated with higher antibody levels [20]. This 
difference in allelic distribution was however not seen 
among the Fulani and Mossi in Burkina Faso [21]. Several 
other single nucleotide polymorphisms (SNPs) in FcγRs 
have been associated with malaria susceptibility but their 
contribution to interethnic difference in malaria sus-
ceptibility is unclear [22–25]. The genes encoding FcγRs 
are interesting and challenging to study for a number of 
reasons. Firstly, the individual genes (FCGR2A, FCγR2B, 
FCGR2C, FCGR3A, FCGR3B) in this cluster exhibit 
high homology between themselves [26]. For instance, 
FCGR2A and FCGR2B have approximately 95 % homol-
ogy in their exons that code for their respective extracel-
lular domains [27]. Secondly, FCGR2C, which encodes 
FcgRIIc, appears to be the product of an unequal crosso-
ver event between FCGR2A and FCGR2B [27]. Lastly, an 
apparent genotype-phenotype mismatch and the possi-
bility that a SNP in one gene can affect the function of 
proteins encoded by a different gene in the FcγRs cluster 
is intriguing [27]. These features present formidable chal-
lenges to the study of this gene cluster and its polymor-
phisms, particularly their introns.
This study focused on three SNPs in the FcγRs gene 
cluster that are yet to be studied in relation to malaria: 
two intronic SNPs (FCGR2C-rs3933769 and FCGR3A-
rs396991) and a functional SNP in the FCGR2B-
rs1050519. The aim of this study was to determine the 
distribution of these SNPs among sympatric Fulani and 
Dogon tribes living in Mali with mild malaria. The study 
further investigated the association of these SNPs with 
various clinical, malariometric and immunological indi-
ces in children with mild malaria. The results of this study 
revealed differences in allelic frequencies in FC2R2C 
(rs3933769) and FCGR3A (rs396991) SNPs among the 
than non‑carriers in the entire study population (p < 0.0001). Carriers of this allele harboured less than half the para‑
sites found in non‑carriers.
Conclusion: Differences in the allelic frequencies of rs3933769 and rs396991 among Fulani and Dogon indirectly 
suggest that these SNPs may influence malaria susceptibility and pathogenesis in the study population. The high fre‑
quency of the FcγRIIC (rs3933769) mutant allele in the Fulani and its subsequent association with low parasite burden 
in the entire study population is noteworthy.
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Fulani and Dogon in the study population. This find-
ing indirectly suggests that the genes may contribute to 
the interethnic variability in malaria susceptibility seen 
among the Fulani and their sympatric neighbours.
Methods
Study participants
The study was conducted in the West African rural vil-
lage of Mantéourou, about 850  km from Bamako, Mali. 
Fulani and Dogon tribes, who have distinct cultural and 
ethnic differences in spite of living within 0.5 km of each 
other, inhabit this village. The Fulani are cattle breeders 
while the Dogon are farmers. The Fulani and Dogon do 
not intermarry [7, 8]. Climatically, Mantéourou is a Sahe-
lian area with dry seasons from October to May and a 
rainy season from June to October. The study comprised 
242 volunteers under the age of 15  years belonging to 
the Fulani (26 %) and Dogon (74 %) tribes. Study volun-
teers were recruited through two cross-sectional sur-
veys conducted at the end of the rainy season (October/
November) and the dry season (March/April) of 2007. 
Volunteers were enrolled into the study through active 
malaria case search. Potential volunteers were clinically 
examined and their medical histories taken. Potential 
volunteers with mild malaria who also satisfied other 
inclusion criteria were recruited into the study after their 
parents/legal guardians had consented to their participa-
tion. Clinical and parasitological data were obtained from 
study volunteers.
Malaria diagnosis, case definition and clinical information
Thick blood films were made and examined as described 
elsewhere [8]. Parasite densities were estimated using an 
assumed leucocyte count of 7500 leucocytes per micro-
litre of blood [7]. A slide was declared negative if no 
parasites were identified after 300 HPF (high-powered 
field) examination. Ten per cent of the slides, randomly 
selected by a physician, were double-read as a qual-
ity control measure. Clinical malaria was defined as the 
presence of fever (axillary temperature of at least 37.5 °C) 
plus the presence of Plasmodium falciparum parasites on 
the thick blood smear, in the absence of any other known 
illnesses. Exclusion criteria included: (1) any confirmed 
or suspected condition of immunosuppression by dis-
eases, including HIV (no screening test has been done for 
this purpose) as determined by the physician; (2) chronic 
administration (defined as more than 14 days) of immu-
nosuppressants or other immune-modifying drugs at the 
start of the study (this included oral steroids and inhaled 
steroids, but not topical steroids); (3) any chronic dis-
eases (cardio-vascular, hepatic and renal) suspected by 
the physician to cause any supplementary risk to the vol-
unteer; and, (4) any other circumstances and conditions 
suspected by the physician to be a risk for volunteer 
health. Axillary temperature of all volunteers was meas-
ured and their spleen size scored by Hackett’s method, 
dichotomized as enlarged or not enlarged.
Genotyping
DNA was extracted from buffy coat using QIAamp DNA 
Blood Mini Kit (QIAgen, Inc.) following manufacturer’s 
protocol and stored at −20 °C. All SNPs were genotyped 
using TaqMan® SNP Genotyping Assays following a wet 
DNA method described elsewhere [21]. In brief, PCR 
amplification was performed in 25 µl reactions using 2 µl 
of genomic DNA (10 ng/µl), 12.5 µl of 2× TaqMan Uni-
versal PCR Master Mix (No AmpErase UNG), 1.25 µl of 
20× working stock of SNP Genotyping Assay, and 9.25 µl 
of DNA free water. The PCR was carried out in an Eppen-
dorf Mastercycler (Eppendorf AG, Hamburg, Germany) 
using a 10-min enzyme activation at 95  °C followed by 
40 cycles with 92 °C for 15 s and 60 °C for 1 min. Allelic 
discrimination was read and analysed by Applied Bio-
systems 7900HT Fast Real-Time PCR System using two 
TaqMan® MGB probes for genotype detection.
Measurement of antibodies
Serum levels of IgG, IgG1 and IgG3 antibodies were 
determined by standard indirect ELISA. Briefly, EIA/RIA 
plates (Costar, Corning, NY, USA) were absorbed over-
night at 4  °C with 50  ml/well of crude percoll-enriched 
lysate of parasite-infected erythrocyte [F32 antigen] 
(10 mg/ml) diluted in sodium carbonate buffer (pH 9.6). 
The plates were blocked with 100 ml of sodium carbon-
ate buffer diluted in 0.5 % bovine serum albumin (BSA) 
for 2 h at 37  °C. After four washings with ELISA wash-
ing buffer [PBS with Tween −20 and 0.15  % Kathon 
(Mabtech, Nacka, Sweden)] in a microplate washer 
(Skan washer 300, CA, USA), the plasma samples 
diluted in incubation buffer, phosphate buffered sulphate 
(PBS  +  0.5  % BSA) 1:1000 (IgG) and 1:400 (IgG1 and 
IgG3) were added in duplicates and incubated for 1 h at 
37  °C. Bound IgG were detected with goat anti-human 
IgG-ALP (1:2000) (Mabtech, Nacka, Sweden) while IgG 
sub-classes were detected with mouse anti-human; IgG1 
1:1000 (SkyBio, Bedfordshire, UK), IgG3 1:1000 (Caltag 
Laboratories, Paisley, UK). ALP-conjugated to goat anti-
mouse Ig (Dakopatts, Glostrup, Denmark) (1:1000) was 
used to detect IgG1, while Streptavidin-ALP (Mabtech) 
1:2000 was added for IgG3 detection. The assays were 
developed with p-nitrophenyl phosphate (Sigma-Aldrich 
GmbH, Steinheim, Germany). The plates were read using 
molecular devices (Vmax® Kinetic microplate reader, 
Menlo Park, USA) at 405  nm and analysed with Soft-
Max® Pro software 5.2 molecular devices. Plasma sam-
ples collected earlier from Fulani individuals residing 
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in Burkina Faso were randomly selected and used as 
the positive controls, and Swedish donors who had not 
experienced malaria and had never travelled to a malaria-
endemic area were used as negative controls. Seroposi-
tivity was based on mean antibody levels +  2SD of ten 
non-malaria-exposed Swedish donors.
Data analysis
Unless otherwise stated, all statistical analysis was imple-
mented using Stata Statistical Software (Release 13, 
StataCorp LP, College Station, TX, USA). Demographic 
variables such as age and sex were compared across ethnic 
groups (Fulani and Dogon) using the Fisher exact test (χ2-
test). Allelic distribution was tested for conformity with 
Hardy-Weinberg equilibrium (HWE) [28]. The genotypic 
and allelic distribution of SNPs studied was also compared 
across ethnic groups using the Fisher exact test. To gain 
insight into the malariometric and immunologic indices 
in the study population, the distribution of these indices 
was compared across ethnic groups using Mann–Whitney 
U test. To determine if the SNPs studied influence malari-
ometric and immunologic indices, a codominant genetic 
model of inheritance was assumed. The effects of SNPs on 
malariometric and immunologic indices were tested using 
Mann–Whitney U test and Kruskal–Wallis analysis of 
ranks. A p <0.05 was deemed statistically significant.
Ethical considerations
Informed consent was obtained from parents or legal 
guardians of study volunteers in a two-step procedure. 
First, oral community consent was obtained prior to 
the study, where the whole community was informed of 
the aim of the study. Secondly, individual consent was 
obtained at the time of blood collection, with all liter-
ate volunteers/guardians signing a consent form, and 
illiterate volunteers consented by fingerprint. The ethi-




The general characteristics of study volunteers are sum-
marized in Table  1. A total of 242 children from Fulani 
(26 %) and Dogon (74 %) tribes participated in this study. 
Study participants included Fulani and Dogon males 
and female no older than 15 years. Median ages of par-
ticipants from the two ethnic groups were comparable 
(p = 0.667) and so were the sex ratios (p = 0.39).
Clinical and malariometric indices among the Fulani 
and Dogon
Haemoglobin (Hb), fever prevalence, parasite density, 
and spleen size were measured to enable comparison 
of malariometric and clinical indices among the Fulani 
and Dogon. Table  1 shows the clinical and malariomet-
ric indices among the study population. The Dogon 
were found to have a significantly higher Hb level than 
the Fulani (p =  0.022). The percentage of children with 
enlarged spleen was higher in the Fulani (56.14  %) 
than the Dogon (31.46  %) (p  <  0.0001). Parasite den-
sity (p < 0.0001) and fever prevalence (p < 0.0001) were 
lower in the Fulani than the Dogon. Parasite density in 
the Dogon was almost 11-fold higher than that found in 
the Fulani (see Table 1). Apart from Hb levels, all other 
variable remained significantly different between Fulani 
and Dogon even after a Bonferroni correction reduced 
significant α level to  ≈0.013. The difference in Hb lev-
els between Fulani and Dogon (p  =  0.022) approached 
significance.
Anti‑malaria specific antibody responses response 
among Fulani and Dogon
The levels IgG, IgG1 and IgG3 responses against F32 
antigen were measured and compared between tribes 
to ascertain if they differed significantly. Table  2 shows 
the antibody levels between the Fulani and Dogon. The 
Fulani had stronger IgG and IgG1 responses than the 
Dogon (p < 0.0001 and p = 0.0013, respectively). Specific 
IgG3 responses were, however, comparable in the Fulani 
and the Dogon (p = 0.63). The difference in IgG and IgG1 
Table 1 General characteristics and  clinical indices 
of study participants
Values in [ ] are median values
* Statistically significant differences (p < 0.05)
Fulani (n = 63) Dogon (n = 179) P value
N [Median] % (Range) N (Median) % (Range)
Demography
 Age (in years)
  0–4 35 55.56 87 48.60 0.667
  5–9 21 33.33 70 39.11
  10–15 7 11.11 22 12.29
 Sex
  Male 32 50.79 102 56.98 0.39
  Female 31 49.21 77 43.02
Clinical data




[119] (2–2060) [1000] (8–10,120) <0.0001*
 Spleno‑
megaly




26 13.90 161 86.63 <0.0001*
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levels between the Fulani and Dogon remained statisti-
cally significant after a Bonferroni correction reduced the 
significant α level to ≈0.017.
Genotypic and allelic distribution rs3933769, rs396991 
and rs1050519 SNPs
In order to determine the genotypes and alleles that 
are over- or under-represented in the study population, 
the three SNPs were genotyped in the two tribes and 
their distributions compared. Table  3 shows the geno-
typic and allelic distribution of the three SNPs in the 
study population. Frequencies of the mutant alleles of 
FCGR2C (rs3933769), FCGR3A (rs396991) and FCGR2B 
(rs1050519) in the entire study population were 0.28, 
0.23 and 0.16, respectively. The mutant allele of FCGR2C 
(rs3933769) occurred more frequently in the Fulani than 
the Dogon (p < 0.0001) while that of FCGR3A (rs396991) 
was found more frequently in the Dogon compared to the 
Fulani (p =  0.0043). The difference in the mutant allele 
frequency of FCGR2B (rs1050519) was however not sta-
tistically significant between the Fulani and Dogon tribes 
(p = 0.064). Apart from FCGR2B (rs1050519), which was 
not in HWE (p < 0.001), the other SNPs studied were in 
conformity with HWE: FCGR2C (rs3933769) (p  >  0.05) 
and FCGRIIIA (rs396991) (p  >  0.05) in the entire study 
population.
Association of SNPs with clinical and malariometric indices
In order to determine the SNPs that may contribute to 
malaria pathogenesis, the associations of SNPs with vari-
ous malariometric and clinical indices was tested. A sum-
mary of SNP association with parasite density, Hb, spleen 
size, and fibril status is shown in Table 4. The rs3933769 
SNP was associated with parasite density in the entire 
study population and carriers of the mutant allele har-
boured less than half of the parasite harboured by non-
carriers (p  <  0.0001). This association was not apparent 
within the Fulani (p = 0.235) and Dogon (p > 0.1) sepa-
rately. The two other SNPs studied were not associated 
with parasite density (p  =  0.064). None of the SNPs 
studied was associated with spleen size, Hb or fever 
prevalence.
Association of SNPs with anti‑malaria specific IgG, IgG1 
and IgG3 antibodies
Humoral immune response is vital in malaria immunity 
and thus the association between SNPs and antibody 
responses was tested. Table 5 summarizes the association 
of SNPs with IgG, IgG1 and IgG3 anti-malaria specific 
antibodies. Apart from rs396991, which was associated 
with IgG1 (p  =  0.023), none of the SNPs studied was 
associated with levels of antibody responses in the entire 
population. The rs396991 was neither associated with 
IgG1 within the Fulani (p = 0.127) nor within the Dogon 
(p =  0.082) populations. The rs396991 was also associ-
ated with IgG3 responses within the Dogon (p = 0.015) 
but no such association was seen within the Fulani group 
(p = 0.314).
Table 2 IgG, IgG1 and IgG3 anti-malaria specific responses among the Fulani and Dogon
* Statistically significant differences (p < 0.05)
Antibodies Fulani (n = 63) Dogon (n = 179) Fulani vs Dogon
Median Range Median Range P value
IgG 10.39 (1.23–80.64) 5.13 (0.87–26.55) <0.0001*
IgG1 34.0 (0.49–3084.5) 9.83 (0.001–67,204.7) 0.0013*
IgG3 0.35 (0.034–5.37) 0.33 (0–2.37) 0.63
Table 3 Genetic and allelic distribution of SNPs among the 
Fulani and Dogon
Genotypic and mutant allele distribution in Fulani, Dogon and entire study 
population
p Values are for mutant allele comparisons between Fulani and Dogon
* Statistically significant differences (p < 0.05)





N % N %
FcγRIIB (rs1050519)
 GG 41 65.08 139 77.65
 GT 16 25.40 32 17.88
 TT 6 9.52 8 4.47
Frequency of mutant allele 22 34.92 40 22.35 0.064
FcγRIIC (rs3933769)
 CC 15 23.81 113 63.13
 CT 42 66.7 50 27.93
 TT 6 9.52 16 8.94
Frequency of mutant allele 48 76.19 66 36.87 <0.0001*
FcγRIIIA (rs396991)
 AA 40 63.49 108 60.34
 AG 19 30.16 57 31.84
 GG 4 6.35 14 7.44
Frequency of mutant allele 23 36.51 71 39.66 0.0043*
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Spleen size, haemoglobin levels, parasite density, 
and fever prevalence among study participants
To better understand the inter-relationships between the 
various malariometric indices, the associations between 
the spleen size, Hb, parasite density, and fever prevalence 
were tested (Table 6). The results showed that the study 
participants with enlarged spleen size had lower Hb 
(p = 0.032). Here again this association was seen in entire 
study population but not within the individual tribes. 
Spleen size was neither associated with parasite density 
(p > 0.1) nor fever prevalence (p > 0.1). Children who had 
fever had higher parasite density than those without fever 
(p < 0.0001).
Discussion
This study found that the allelic frequencies of rs396991 
and rs3933769 were different between the Fulani and 
Dogon. This observation is noteworthy because of 
the confirmed and suggested roles of these SNPs. The 
rs396991 SNP represents a change from phenylalanine 
(F) to valine (V) at position 158 in the Fc fragment of 
IgG, low affinity IIIa, receptor (CD16a) gene [29]. The 
mutant allele of this SNP binds IgG1 and IgG3 with 
a higher affinity than the wild type, which binds fewer 
immune complexes thereby reducing the potential of 
inflammatory response [29, 30]. Functional mutation in 
the FCGR3A gene can potentially influence immune-
mediated diseases since the FcγRIIIa receptors are 
found on several immune cells and constitute a vital 
link between humoral and cellular immunity. Thus, the 
finding that the rs396991 mutant allele occurs at higher 
frequency in the Dogon, who are more susceptible to 
malaria relative to Fulani, is alluring. The rs396991 has 
been shown to influence several immune-mediated 
diseases [31–34]. For instance, the homozygous wild 
genotype of rs396991 was under-represented in HIV-
infected patients with Kaposi sarcoma [31]. This SNP 
is also suggested to play a limited role in rheumatoid 
arthritis, which is an immune-mediated disease [34]. 
The rs396991 is yet to be studied in relation to malaria 
but data from this study suggest that this SNP may play a 
role in malaria pathogenesis.
Table 5 Association of SNPs with antibody levels
Comparison of antibody levels in participates with wild and mutant alleles
Comparisons were done in the two tribes separately and in the entire study
* Statistically significant differences (p < 0.05)
SNP (gene) Alleles Comparison Antibody responses (Mean Log 10)
Fulani Dogon Fulani + Dogon
IgG IgG1 IgG3 IgG IgG1 IgG3 IgG IgG1 IgG3
(FcγRIIB (rs1050519) Ref G GG vs TT/GT 9.267 29.79 0.429 5.49 8.897 0.33 5.76 10.39 0.3475
Alt T 10.86 37.08 0.30 3.95 11.90 0.34 5.16 14.03 0.33
p Value 0.795 0.908 0.105 0.301 0.317 0.755 0.956 0.251 0.439
FCγRIIC (rs3933769) Ref C CC vs TT/CT 14.61 44.31 0.33 5.35 10.21 0.35 5.71 11.31 0.34
Alt T 7.74 28.76 0.35 4.63 7.35 0.33 5.81 10.45 0.34
p Value 0.367 0.392 0.594 0.311 0.706 0.790 0.872 0.670 0.933
FCγRIIIA (rs36991) Ref A AA vs GG/AG 9.83 12.27 0.35 5.09 6.66 0.32 5.74 8.31 0.34
Alt G 11.29 54 0.32 5.33 13.06 0.35 5.94 18.56 0.35
p Value 0.898 0.127 0.314 0.839 0.082 0.015* 0.712 0.023* 0.158
Table 6 Relationship between various malariometric indices
Mann–Whitney rank sum test was used to test all associations except the association between fever and parasite density, which was tested with Spearman’s 
correlation. Values in this Table are p values, except the comparison between fever and parasitaemia, where correlation coefficient is reported in addition to the p 
value
* Statistically significant differences (p < 0.05)
Comparison Fulani (n = 63) Dogon (n = 179) Fulani + Dogon (n = 242)
Spleen size/Hb 0.440 0.116 0.032*
Spleen size/parasitaemia 0.459 0.701 0.117
Spleen size/fever 0.834 0.767 0.229
Fever/parasite density r = 0.140, p = 0.274 r = 0.256, p = 0.005* r = 0.382, P < 0.001*
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In line with previous studies, the Fulani had higher 
levels of anti-malaria specific IgG, IgG1 and IgG3 than 
the Dogon [19, 35]. However, this present study has 
expanded knowledge by further showing an association 
between rs396991 mutant allele and higher levels of IgG3 
in the Dogon tribe. This is interesting considering the 
fact this SNP was associated with higher levels of IgG in 
Hutchison lymphoma patients [36]. The variable distribu-
tion of rs396991 among Fulani and Dogon, as well as its 
association with IgG, could be an indication of a possible 
role for this SNP in malaria susceptibility.
This study compared various malariometric indices 
among the sympatric tribes and, consistent with previ-
ous studies in The Gambia, Burkina Faso, Sudan and Mali 
[5, 6, 20], an enlarged spleen was more frequently seen 
among the Fulani compared to the Dogon. Also, consist-
ent with previous studies is the finding of lower Hb levels, 
parasite density and fever prevalence in the Fulani rela-
tive to the Dogon [5, 15, 37]. Although these variations 
in malariometric indices among Fulani and non-Fulani 
sympatric neighbours have been known for decades, 
there is still no satisfactory explanation for some of them. 
For instance, the pronounced splenomegaly in the Fulani 
is poorly explained. A recent model explains that an 
innate propensity of the spleen to stringently retain para-
sitized red blood cells causes enlargement of the spleen, 
lowers Hb levels and reduces parasite density [38]. This 
present study showed an association between enlarged 
spleen and lower Hb levels but not parasite density. The 
data on spleen size, Hb levels, parasite density, and fever 
prevalence suggest that spleen size could be an important 
malariometric index.
Besides being more frequent in the Fulani than the 
Dogon, the intronic rs3933769 SNP of FCGR2C appeared 
to influence parasite density in the study population. 
Study participants with the mutant allele harboured 
fewer than half the parasites found in their counterparts 
with the ancestral allele. The FcγRIIc is suggested to play 
an important role in parasite clearance by effectively 
bridging humoral and cellular immunity [39]. This finding 
is particularly interesting considering that introns have 
been traditionally viewed as non-functional. Intronic 
SNPs have gained currency lately with the emergence 
of evidence on their possible functional roles [40, 41]. 
This finding adds to an increasing body of evidence that 
suggests roles for intronic SNPs. The intronic SNPs of 
FCγR2C are even more interesting considering that this 
gene exhibits a genotype-phenotype mismatch [27]. Hei-
jden et al. recently found a novel intron 7 SNP of FCγRIIC 
that prevented some Caucasians with the FCγRIIC-ORF 
genotype from expressing FcγRIIb/c. Some individuals 
in the same population with the FCγRIIC-Stop geno-
type, which is thought to be a pseudogene, expressed 
the FcγRIIb/c receptor [27]. The extracellular domains 
of FcγRIIc and FcγRIIb are completely identical, a situa-
tion that further complicates the study of this gene clus-
ter. Possibly several other SNPs or copy number variation 
(CNV) in FCγRIIC affects the expression of FcγRIIc on 
immune cells and influences their ability to induce anti-
body-dependent cellular cytotoxicity ADCC or alter the 
balance between activating and inhibitory signals [42]. 
Such polymorphisms may even affect the expression and 
function of other FcγRs than FcγRIIc [27]. The findings of 
this study leave room for speculating a role for rs3933769 
in malaria pathogenesis and susceptibility. Further stud-
ies will be needed to make this SNP a bona fide malaria 
candidate polymorphism.
Some of the associations reported in this study were 
found in the entire study population and not in the two 
tribes separately. For instance, the associations between 
rs3933769 and parasite density, rs396991 and IgG1, 
enlarge spleen and lower Hb were all found in the entire 
study population only. These observations should be 
interpreted with care because even though the unequal 
numbers of Fulani and Dogon in this study do not nec-
essarily pose a statistical problem, it could have reduced 
the power to detect statistical significance in two tribes 
separately.
Conclusion
Taken together, this study confirms previous studies 
that showed interethnic difference between the Fulani 
and non-Fulani sympatric tribes with regard to clinical, 
malariometric and immunological indices. In the further-
ance of knowledge, this study shows that the allelic dis-
tribution of two FCγR SNPs is different in the Fulani and 
Dogon living in sympatry in Mali. The study also shows 
that two of the SNPs are associated with parasite density 
and IgG1 and IgG3 responses. This study did not aim to 
determine the association between these FCγR SNPs and 
malaria. Further studies will be needed to determine the 
possible roles of these SNPs in malaria pathogenesis.
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